Pregnancy outcomes in women with advanced HIV infection in Italy

AIDS Patient Care and STDs

Volumn 25, Issue 11, 2011, Pages 639-645

  Baroncelli, Silvia ^a   Tamburrini, Enrica ^b   Ravizza, Marina ^c   Pinnetti, Carmela ^b   Dalzero, Serena ^c   Scatà, Manuela ^d   Crepaldi, Alessandra ^e   Liuzzi, Giuseppina ^f   Molinari, Atim ^g   Vimercati, Antonella ^h   MacCabruni, Anna ⁱ   Francisci, Daniela ^j   Rubino, Elena ^k   Floridia, Marco ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c SAN PAOLO HOSPITAL   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^g UNIVERSITY HOSPITAL OF PARMA   (Italy)

^h UNIVERSITY OF BARI   (Italy)

ⁱ FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^j UNIVERSITY OF PERUGIA   (Italy)

^k UNIVERSITY OF PALERMO   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ADULT; APGAR SCORE; ARTICLE; BIRTH WEIGHT; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DELIVERY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; ITALY; MAJOR CLINICAL STUDY; PREGNANCY OUTCOME; PREMATURE LABOR; PUERPERIUM; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; FEMALE; GESTATIONAL AGE; HIV INFECTIONS; HUMANS; ITALY; LOGISTIC MODELS; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VIRAL LOAD; YOUNG ADULT;

EID: 80055033949     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2011.0172     Document Type: Article

References (37)

1. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. May 24, 2010; pp 1-117. http://aidsinfo.nih.gov/ContentFiles/ PerinatalGL.pdf (Last accessed January 2011).
2. UnAIDS/WHO. AIDS epidemic update: November 2009. WHO Library Cataloguing-in-Publication Data. 2009.
3. Paintsil E, Andiman WA. Update on successes and challenges regarding mother-to-child transmission of HIV. Curr Opin Pediatr 2009;21:94-101.
4. Chen JL, Philips KA, Kanouse DE, Collins RL, Miu A. Fertility desires and intentions of HIV-positive men and women. Fam Plann Perspect 2001;33:144-152, 165.
5. Saada M, Le Chenadec J, Berrebi A, et al. Pregnancy and progression to AIDS: results of the French prospective cohorts. SEROGEST and SEROCO Study Groups. AIDS 2000; 14:2355-2360.
6. Weisser M, Rudin C, Battegay M, Pfluger D, Kully C, Egger M. Does pregnancy influence the course of HIV infection? Evidence from two large Swiss cohort studies. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:404-410.
7. Watts DH, Lu M, Thompson B, et al. Treatment interruption after pregnancy: Effects on disease progression and laboratory findings. Infect Dis Obstet Gynecol 2009;2009:456717.
8. Tai JH, Udoji MA, Barkanic G, et al. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy. J Infect Dis 2007;196:1044-1052. (Pubitemid 47580299)
9. Onen NF, Nurutdinova D, Sungkanuparph S, Gase D, Mondy K, Overton ET. Effect of postpartum HIV treatment discontinuation on long-term maternal outcome. J Int Assoc Physicians AIDS Care 2008;7:245-251.
10. Melekhin VV, Shepherd BE, Jenkins CA, et al. Postpartum discontinuation of antiretroviral therapy and risk of maternal AIDS-defining events, non-AIDS-defining events, and mortality among a cohort of HIV-1-infected women in the United States. AIDS Patient Care STDS 2010;24:279-286.
11. Floridia M, Ravizza M, Tamburrini E, et al. Diagnosis of HIV infection in pregnancy: data from a national cohort of pregnant women with HIV in Italy. Epidemiol Infect 2006; 134:1120-1127. (Pubitemid 44336390)
12. Bertino E, Spada E, Occhi L, et al. Neonatal anthropometric charts: The Italian neonatal study compared with other European studies. J Pediatr Gastroenterol Nutr 2010;51:353-361.
13. Scheuerle A, Covington D. Clinical review procedures for the Antiretroviral Pregnancy Registry. Pharmacoepidemiol Drug Saf 2004;13:529-536. (Pubitemid 39214031)
14. CDC. 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. MMW 1992;41:RR-17.
15. Confavreux C, Hutchinson M, Hours MM, Cortinovis- Tourniaire P, Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 1998;339:285-291. (Pubitemid 28366416)
16. Tincani A, Faden D, Tarantini M, et al. Systemic lupus erythematosus and pregnancy: a prospective study. Clin Exp Rheumatol 1992;10:439-446.
17. Blair JM, Hanson DL, Jones JL, Dworkin MS. Trends in pregnancy rates among women with human immunodeficiency virus. Obstet Gynecol 2004;103:663-668. (Pubitemid 40459025)
18. Linas BS,MinkoffH,CohenMH, et al.Relative time topregnancy among HIV-infected and uninfected women in the Womens Interagency HIV Study, 2002-2009. AIDS 2011;25:707-711.
19. Goetghebuer T, Haelterman E, Marvillet I, et al. Vertical transmission of HIV in Belgium: A 1986-2002 retrospective analysis. Eur J Pediatr 2009;168:79-85.
20. Arya M, Levison J, Giordano TP. Ongoing barriers to HIV testing during pregnancy: A need for media campaigns addressing low knowledge about perinatal HIV transmission among women in the United States. AIDS Patient Care STDs 2010;24:71-72.
21. Finocchario-Kessler S, Dariotis JK, Sweat MD, et al. Do HIVinfected women want to discuss reproductive plans with providers, and are those conversations occurring? AIDS Patient Care STDs 2010;24:317-323.
22. Ford N, Mofenson L, Kranzer K, et al. Safety of efavirenz in first-trimester of pregnancy: A systematic review and metaanalysis of outcomes from observational cohorts. AIDS 2010; 24:1461-1470.
23. Hsu H, Rydzak C, Cotich K, et al. Quantifying the risks and benefits of efavirenz use in HIV-infected women of childbearing age in the USA. HIV Med 2011;12:97-108.
24. Ekouevi DK, Coffie PA, Ouattara E, et al. Pregnancy outcomes in women exposed to efavirenz and nevirapine: an appraisal of the IeDEA West Africa and ANRS Databases, Abidjan, Côte dIvoire. J Acquir Immune Defic Syndr 2011; 56:183-187.
25. Brogly SB, Abzug MJ, Watts DH, et al. Birth defects among children born to human immunodeficiency virus-infected women: Pediatric AIDS clinical trials protocols 219 and 219C. Pediatr Infect Dis J 2010;29:721-727.
26. Watts DH. Treating HIV during pregnancy: an update on safety issues. Drug Saf 2006;29:467-490. (Pubitemid 43855080)
27. Cooper ER, Charurat M, Mofenson L, et al. Combination antiretroviral strategies for the treatment of pregnant HIV- 1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 2002;29:484-494. (Pubitemid 34456340)
28. Ioannidis JP, Abrams EJ, Ammann A, et al. Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads < 1000 copies/ml. J Infect Dis 2001;183:539-545. (Pubitemid 32147509)
29. Miotti PG, Liomba G, Dallabetta GA, Hoover DR, Chiphangwi JD, Saah AJ. T lymphocyte subsets during and after pregnancy: Analysis in human immunodeficiency virus type 1-infected and -uninfected Malawian mothers. J Infect Dis 1992;165:1116-1119.
30. Ekouevi DK, Inwoley A, Tonwe-Gold B, et al. Variation of CD4 count and percentage during pregnancy and after delivery: Implications for HAART initiation in resource-limited settings. AIDS Res Hum Retroviruses 2007;23:1469-1474.
31. Melo VH, Pinto JA, Freimanis-Hance L, et al. Postpartum changes in plasma viral load and CD4 percentage among HIV-infected women from Latin American and Caribbean countries: The NISDI Perinatal Study. Mem Inst Oswaldo Cruz 2011;106:97-104.
32. Valkenburg-van den Berg AW, Sprij AJ, Oostvogel PM, et al. Prevalence of colonisation with group B Streptococci in pregnant women of a multi-ethnic population in The Netherlands. Eur J Obstet Gynecol Reprod Biol 2006;124:178-183. (Pubitemid 43148929)
33. Tolosa JE, Chaithongwongwatthana S, Daly S, et al. The International Infections in Pregnancy (IIP) study: Variations in the prevalence of bacterial vaginosis and distribution of morphotypes in vaginal smears among pregnant women. Am J Obstet Gynecol 2006;195:1198-1204. (Pubitemid 44740414)
34. European Collaborative Study; Swiss Mother and Child HIV Cohort Study. Combination antiretroviral therapy and duration of pregnancy. AIDS 2000;14:2913-2920.
35. Cotter AM, Garcia AG, Duthely ML, Luke B, OSullivan MJ. Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth? J Infect Dis 2006;193:1195-201.
36. Martin F, Navaratne L, Khan W, et al. Pregnant women with HIV infection can expect healthy survival: Three-year follow- up. J Acquir Immune Defic Syndr 2006;43:186-192. (Pubitemid 44454812)
37. Tungsiripat M, Drechsler H, Aberg JA. Discontinuation of antiretroviral therapy postpartum: No evidence for altered viral set point. J Acquir Immune Defic Syndr 2007;44:116-117. (Pubitemid 46052230)